Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisolone in COPD with sputum eosinophilia
2005-002138-36Phase 2Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Prednisolone + alendronic acid with Placebo + alendronic acid (2 arms). Primary endpoints: Decline in lung function and Annual exacerbation rate. Started Feb 2006; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-002138-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002138-36.